Oliver Lagore Vanvalin Investment Group Trans Medics Group, Inc. Transaction History

Oliver Lagore Vanvalin Investment Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$36.74 - $81.08 $2,902 - $6,405	-79 Reduced 32.51%	164 $12,000
Q3 2023 Nov 09, 2023	SELL	$53.47 - $96.07 $1,122 - $2,017	-21 Reduced 7.95%	243 $13,000
Q2 2023 Aug 08, 2023	BUY	$66.23 - $88.73 $10,530 - $14,108	159 Added 151.43%	264 $22,000
Q1 2023 Jun 20, 2023	BUY	$53.63 - $82.33 $1,126 - $1,728	21 Added 25.0%	105 $7,000
Q4 2022 Mar 02, 2023	BUY	$39.08 - $64.29 $273 - $450	7 Added 9.09%	84 $5,000
Q3 2022 Nov 15, 2022	BUY	$31.56 - $55.75 $2,430 - $4,292	77 New	77 $3,000

345

30.5M

671K

858K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.29B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.